Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Patent
1995-05-13
1999-10-26
Degen, Nancy
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
435 9141, 4351723, 4353201, C12N 1500, C12N 1563, C12Q 170
Patent
active
059725974
ABSTRACT:
What are disclosed are methods for modifying the genome of vaccinia virus to produce vaccinia mutants, particularly by the introduction into the vaccinia genome of exogenous DNA; modified vaccinia prepared by such methods; certain DNA sequences and unmodified and genetically modified microorganisms involved as intermediates in such methods; and methods for infecting cells and host animals with such vaccinia mutants to provoke the amplification of exogenous DNA and proteins encoded by the exogenous DNA, including antigenic proteins, by said cells and host animals.
REFERENCES:
patent: 4088748 (1978-05-01), McAleer et al.
patent: 4113712 (1978-09-01), Funakoshi
patent: 4129646 (1978-12-01), McAleer et al.
patent: 4138287 (1979-02-01), Andersson et al.
patent: 4162192 (1979-07-01), Mizuno et al.
patent: 4237224 (1980-12-01), Cohen et al.
patent: 4322499 (1982-03-01), Baxters et al.
patent: 4399216 (1983-08-01), Axel et al.
patent: 4603112 (1986-07-01), Paoletti et al.
patent: 4710463 (1987-12-01), Murray et al.
patent: 4722848 (1998-02-01), Paoletti et al.
patent: 4769330 (1988-09-01), Paoletti et al.
patent: 5110587 (1992-05-01), Paoletti et al.
patent: 5244792 (1993-09-01), Burke et al.
patent: 5338683 (1994-08-01), Paoletti et al.
Baxyby, Progr. Med. Virol. 19 (1975) 215-246.
Bolivar et al., Gene 2, 95-113 (1977).
Bossart et al., Chem. Abstr. 89 (1978) 56,251 n.
Campione-Piccardo et al., J. Virol. 31, 281-287 (1979).
Chem. Abstracts, 10th Coll. Index, (1977-1981), vols. 86-95, Virus, Animal, Vaccinia Virus.
Colbere-Garapin, Prod. Natl. Acad. Sci. USA 76, 3755-3759 (1979).
Comparative Diagnosis of Viral Diseases, vol. III, ch. 6, p. 277, Academic Press, New York, 1981.
Comprehensive Virology, Fraenkel-Conrad et al., vol. 3, ch. 5, pp. 405, 427, Plenum Press, New York.
Downie et al., Ann. Rev. Microbiol. 10 (1959) 237-252.
Ensinger et al., "Marker Rescue etc.", J. Virol. 48(2); 1983, 419-428.
Fenner, Virology 8 (1959) 499-507.
Fenner, Virology 5 (1958) 502-529.
Graham et al., Virology 52, 456-467 (1973).
Hamer et al., Nature 281, 35-40 (1979).
Joklik, Bacteriological Reviews 30 (1966) 33-66.
Jones et al., "Mapping of the Vaccinia Virus etc.", J. Virol. 49(1); 1984, 72-77.
Katz et al., C.A. 89 #39241s (1978) of J. Antimicrob. Chemother. 1978 4(2): 159-162, Genetic Recombination Between Temperature Sensitive Mutuant and IBT Resistant Mutant of Vaccinia Virus.
Kruczek-Juszczyk C.A. 92#126795f, (1980) of Ann. Univ. Mariae Curie Sect. C, 1978, 33: 1-8, Interferon Introduction by Viral Nucleic Acids in Chick Embryo Fibroblasts.
Mackett et al., J. Gen. Virol. 45 (1979) 683-701.
Mackett et al., "Vaccinia Virus etc.", Proc. Nat'l. Acad. Sci. USA 79, 1982, 7415-7419.
Miller et al., J. Gen. Virol. 38 (1977) 135-147.
Mocarski et al.: Cell 22, 243 (1980).
Morse et al.: J. Virol. 26, 389 (1978).
Moss et al-J. of Virology, vol. 40, No. 2, Nov. 1981, pp. 387-389, & 393-395.
Moss et al-Chem. Abst. vol. 95 (1981) p.217, 559k.
Nakano et al., "Molecular Genetics of Vaccinia etc.", Proc. Nat'l. Acad. Sci. USA 79, 1982, 1593-1596.
Nippon Zoki Pharm. C.A. 94 #7711g, (1981) of Jpn. Kokai Tokkyo Koho 8087724, Jul. 2, 1980, Selective Immune Enhancer.
Panicali et al., J. Virol. 37, 1000-1010 (1981).
Panicali et al., "Construction of Live Vaccines etc.", Proc. Nat'l. Acad. Sci. USA 80, 1983, 5364-5368.
Panicali et al., "Construction of Live Vaccines etc.", Proc. Nat'l. Acad. Sci. USA 79, 1982, 4927-4931.
Panicali et al., C.A. 94 #135967g, 1981 of J. Virol., 1981, 37(3): 1000-10, Two Major DNA Variants Present in Serially Propagated Stocks of the WR Strains of Vaccinia Virus.
Paoletti et al., Jan. 1984, PNAS 81:193-197.
Post et al., Cell 25 (1981) 227-2333.
Sam et al., Ann. Virol. 132 E. 135-150 (1981).
Sarver et al., Ann. Virol. 132 E. 135-150 (1981).
Schuemperli et al.-Chem. Abst. vol. 92 (1980) p. 124, 733k.
Shigeru et al., C.A. 86., #3119g, 1977 of Yakugaku Zasshi (1976)96(10): 1247-1254, Protein Inhibitors of Gastric Acid Secretion Isolated From Vaccinia Virus-Infected Tissues.
Shigeru, C.A. 88., #55061t, 1978 of Japan Kokai 77116402, Sep. 29, 1977, Gastric Juice Secretion-Inhibiting Protein From Vaccinia Virus Infected Animal Tissues.
Shimotohno et al., Cell 26, 66-77 (1981).
Smiley, Nature 285 (1980) 333-335.
Smith. G.L. et al., Dec. 1983 PNAS 80:7155-59.
Smith. G.C. et al., Apr. 7, 1983, Nature 302; 490-495.
Sveda et al., Proc. Natl. Acad. Sci. USA 78, 5488-5492 (1981).
Third Povirus-Iridovirus Workshop, Sep. 15-18, 1980, Workshop Program.
Villarreal et al., Science 196, 183-185 (1977).
Virology, Dulbecco et al., Ch. 56, pp. 1079 and 1082-1085, Harper & Row, Hagerstown.
Watson et al., Science vol. 218, pp. 381-384 (1982).
Weir et al., "Mapping of the Vaccine Virus etc.", Proc. Nat'l. Acad. Sci. USA 79, 1982, 1210-1214.
Wigler et al., Cell 11, 223-232 (1977).
Wigler et al., Proc. Natl. Acad. Sci. USA 76, 1373-1376 (1979).
Williams, N., Dec. 1, 1983, Nature 306:427.
Wittek et al., J. Virol. 23 (1977) 669-678.
Woodroofe et al., Virology 16 (1962) 334-341.
Woodroofe et al., Virology 12 (1960) 272-282.
Badgy et al., Methods in Enzymology, vol. 45., 669-678 (1976).
Itakura et al., Science, 1056-1060 (1974).
Bonnerjea et al., vol. 4, 954-958 (1986).
Sofer et al., vol. 1, 198-203 (1983).
Abstracts from Pox-Iridovirus Meeting, Cold Spring Harbor, Sep. 20-23, 1982, J. Holowczak, Rutgers Medical School, Riccardo Witter, University of Lausanne, Participant Housing List.
Declaration of Marion Perkus, Nov. 10, 1993, In re: European Patent No. 0 110 385 B1, European Appln. No. 83 111976.3..sub.1.
Panicali Dennis
Paoletti Enzo
Degen Nancy
Health Research Incorporated
Schwartzman Robert
LandOfFree
Methods using modified vaccinia virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods using modified vaccinia virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods using modified vaccinia virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-762152